News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,317 Results
Type
Article (87459)
Company Profile (760)
Press Release (773077)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233063)
Career Advice (4140)
Deals (39797)
Drug Delivery (138)
Drug Development (91257)
Employer Resources (203)
FDA (18285)
Job Trends (17402)
News (397417)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (146)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (251)
Approvals (18314)
Artificial intelligence (499)
Autoimmune disease (79)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (484)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (513)
Cancer (4011)
Cardiovascular disease (340)
Career advice (3560)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (689)
Cervical cancer (33)
Clinical research (75591)
Collaboration (1403)
Company closure (4)
Compensation (940)
Complete response letters (59)
COVID-19 (2959)
CRISPR (81)
C-suite (600)
Cystic fibrosis (138)
Data (4575)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (455)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (237)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98874)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133084)
Executive appointments (994)
FDA (20783)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1268)
Gene editing (173)
Generative AI (50)
Gene therapy (549)
GLP-1 (1023)
Government (5386)
Grass and pollen (7)
Guidances (349)
Healthcare (20938)
HIV (48)
Huntington's disease (38)
IgA nephropathy (64)
Immunology and inflammation (244)
Immuno-oncology (21)
Indications (53)
Infectious disease (3205)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (79)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (578)
Lymphoma (267)
Machine learning (31)
Management (66)
Manufacturing (644)
MASH (141)
Medical device (14878)
Medtech (14903)
Mergers & acquisitions (22754)
Metabolic disorders (1164)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (62)
Neuroscience (2728)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (58)
Obesity (563)
Opinion (314)
Ovarian cancer (135)
Pain (167)
Pancreatic cancer (172)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (322)
Peanut (57)
People (66289)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23315)
Phase II (32813)
Phase III (24722)
Pipeline (2748)
Policy (295)
Postmarket research (3554)
Preclinical (10513)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (681)
Real estate (7422)
Recruiting (79)
Regulatory (28043)
Reports (65)
Research institute (2691)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1054)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (129)
Last 7 days (758)
Last 30 days (2687)
Last 365 days (33597)
2025 (26853)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51002)
Australia (8963)
California (9533)
Canada (2882)
China (914)
Colorado (405)
Connecticut (427)
Delaware (271)
Europe (117167)
Florida (1404)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (52)
Indiana (466)
Iowa (20)
Japan (327)
Kansas (124)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1288)
Massachusetts (7165)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2650)
New Mexico (32)
New York (2594)
North Carolina (1421)
North Dakota (10)
Northern California (4329)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1983)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3637)
Tennessee (150)
Texas (1494)
United States (35228)
Utah (283)
Virginia (250)
Washington D.C. (84)
Washington State (823)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,317 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Generation Lab raises $11 million, becoming Accel’s first longevity bet
October 23, 2025
·
1 min read
Press Releases
Trialogix Launches to Transform Clinical Trial Design with AI-Powered Optimization Platform
October 23, 2025
·
1 min read
Press Releases
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
• The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. • In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengthening Bachem’s presence in the US market.
October 23, 2025
·
2 min read
Press Releases
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook
October 23, 2025
·
3 min read
Press Releases
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
October 23, 2025
·
3 min read
Press Releases
L7 Informatics Calls on Life Sciences Leaders to Address the AI-Readiness Gap Highlighted by Gartner
October 23, 2025
·
1 min read
Press Releases
Kantify Reaches New Milestone in AI-Driven Drug Discovery: 10 Billion Molecules Analyzed Per Day and a Major Advance in a Rare Cancer
October 23, 2025
·
1 min read
Press Releases
Sartorius hosts CGT forum in Boston to drive innovation in Cell & Gene Therapies
October 23, 2025
·
1 min read
Press Releases
Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity
◆ VIAL-INHBE is a novel, GalNAc-conjugated INHBE (Activin E) siRNA for the treatment of obesity and other cardiometabolic indications with a projected Q6M dosing intervall ◆ VIAL-INHBE DIO mouse model data demonstrated compelling fat-selective weight-loss and lean mass preservation ◆ Combination therapy with a low-dose GLP-1 resulted in synergistic weight loss and lean mass preservation that was maintained off-GLP-1 treatment ◆ A Phase 1 open-label study in Australia is initiating to evaluate safety, pharmacokinetics, and pharmacodynamic responses ◆ Interim subcutaneous safety and pharmacokinetic data are expected in H1 2026
October 23, 2025
·
1 min read
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 23, 2025
·
74 min read
·
BioSpace Editorial Staff
1 of 86,132
Next
